2.705
전일 마감가:
$2.60
열려 있는:
$2.57
하루 거래량:
534.23K
Relative Volume:
0.50
시가총액:
$154.29M
수익:
-
순이익/손실:
$-82.44M
주가수익비율:
-1.4388
EPS:
-1.88
순현금흐름:
$-66.75M
1주 성능:
-2.51%
1개월 성능:
-13.65%
6개월 성능:
+25.92%
1년 성능:
-58.35%
Black Diamond Therapeutics Inc Stock (BDTX) Company Profile
명칭
Black Diamond Therapeutics Inc
전화
617-417-5868
주소
ONE MAIN STREET, 14TH FLOOR, CAMBRIDGE, MA
BDTX을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
BDTX
Black Diamond Therapeutics Inc
|
2.71 | 156.57M | 0 | -82.44M | -66.75M | -1.88 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.05 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
601.70 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
465.56 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
665.90 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
311.31 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Black Diamond Therapeutics Inc Stock (BDTX) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-07-01 | 재개 | Raymond James | Outperform |
2024-07-31 | 개시 | Raymond James | Outperform |
2023-07-14 | 개시 | Piper Sandler | Overweight |
2023-06-30 | 업그레이드 | Stifel | Hold → Buy |
2023-06-28 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
2023-06-27 | 업그레이드 | Wedbush | Neutral → Outperform |
2022-03-29 | 다운그레이드 | Wedbush | Outperform → Neutral |
2022-03-22 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
2021-09-30 | 개시 | Stifel | Hold |
2021-01-07 | 개시 | Wedbush | Outperform |
2020-11-24 | 개시 | Berenberg | Buy |
2020-05-04 | 개시 | H.C. Wainwright | Buy |
2020-02-24 | 개시 | Canaccord Genuity | Buy |
2020-02-24 | 개시 | Cowen | Outperform |
2020-02-24 | 개시 | JP Morgan | Overweight |
2020-02-24 | 개시 | Jefferies | Buy |
모두보기
Black Diamond Therapeutics Inc 주식(BDTX)의 최신 뉴스
Are Medical Stocks Lagging Black Diamond Therapeutics (BDTX) This Year? - sharewise.com
Black Diamond Therapeutics And 2 Promising Penny Stocks For Savvy Investors - Yahoo Finance
Do Its Financials Have Any Role To Play In Driving Black Diamond Therapeutics, Inc.'s (NASDAQ:BDTX) Stock Up Recently? - simplywall.st
Black Diamond Therapeutics Inc. Building a Base Near Support2025 Breakouts & Breakdowns & Long-Term Growth Stock Strategies - kangso.co.kr
Will Black Diamond Therapeutics Inc. stock go up soonOptions Play & Verified Momentum Stock Watchlist - Newser
Published on: 2025-08-17 21:53:04 - Newser
Recovery Signals Appearing in Black Diamond Therapeutics Inc. Charts2025 Buyback Activity & AI Powered Trade Plan Recommendations - sundaytimes.kr
Is Black Diamond Therapeutics Inc. Forming a Consolidation BaseJuly 2025 Reactions & Safe Swing Trade Setup Alerts - metal.it
Will Black Diamond Therapeutics Inc. Stock Benefit from AI and Green Energy TrendsWeekly Risk Summary & Weekly High Potential Stock Alerts - Newser
Predicting Black Diamond Therapeutics Inc. trend using moving averagesChart Signals & High Accuracy Swing Trade Signals - Newser
How to use a screener to detect Black Diamond Therapeutics Inc. breakouts2025 Biggest Moves & Safe Swing Trade Setups - Newser
Elliott Wave Theory Predicts Pullback in Black Diamond Therapeutics Inc.July 2025 Rallies & High Conviction Buy Zone Alerts - metal.it
Published on: 2025-08-16 21:08:00 - Newser
Competitive Positioning of Black Diamond Therapeutics Inc.: Is It Leading or LaggingDay Trade & Community Consensus Trade Alerts - Newser
Has Black Diamond Therapeutics Inc. formed a bullish divergenceLong Setup & Accurate Entry/Exit Alerts - Newser
Machine Learning Models Forecast Black Diamond Therapeutics Inc. UptickWeekly Trend Recap & AI Enhanced Trade Execution Alerts - 선데이타임즈
Tick level data insight on Black Diamond Therapeutics Inc. volatilityWeekly Market Outlook & Momentum Based Trading Ideas - Newser
Should you wait for a breakout in Black Diamond Therapeutics Inc.July 2025 Fed Impact & Long-Term Safe Investment Ideas - Newser
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Shares Sold by XTX Topco Ltd - Defense World
Price action breakdown for Black Diamond Therapeutics Inc.Index Update & Reliable Price Breakout Alerts - Newser
Chart based analysis of Black Diamond Therapeutics Inc. trendsQuarterly Investment Review & Capital Efficient Trade Techniques - Newser
Brokers Set Expectations for BDTX Q3 Earnings - Defense World
Black Diamond (BDTX) Q2 Loss Narrows 47% - AOL.com
Analysts Offer Predictions for BDTX FY2026 Earnings - Defense World
What moving averages say about Black Diamond Therapeutics Inc.Earnings Risk Report & Real-Time Volume Spike Alerts - Newser
Will Breakout in Black Diamond Therapeutics Inc. Sustain Through Next Week2025 Institutional Moves & Consistent Profit Alerts - metal.it
HC Wainwright Has Lowered Expectations for Black Diamond Therapeutics (NASDAQ:BDTX) Stock Price - Defense World
Why Black Diamond Therapeutics Inc. stock attracts strong analyst attentionPrice Movement and Market Sentiment Analysis - Newser
Top Risks to Consider Before Buying Black Diamond Therapeutics Inc. StockInstitutional Holding Behavior Pattern Analysis - Newser
Black Diamond Therapeutics Reports Strong Financial Turnaround - TipRanks
Black Diamond Therapeutics, Inc. (BDTX) Rated Outperform as Lead Drug Shows Promise - MSN
What makes Black Diamond Therapeutics Inc. stock price move sharplyDaily Pattern Analysis with Return Forecast - Newser
H.C. Wainwright Maintains Black Diamond Therapeutics(BDTX.US) With Buy Rating, Cuts Target Price to $10 - 富途牛牛
H.C. Wainwright lowers Black Diamond Therapeutics stock price target on delayed launch - Investing.com Canada
Published on: 2025-08-11 06:28:53 - Newser
Black Diamond:HC Wainwright lowers PT to $10 from $12, maintains Buy rating. - AInvest
News impact scoring models applied to Black Diamond Therapeutics Inc.Fundamental Forecast for Undervalued Stocks - Newser
When is the best time to exit Black Diamond Therapeutics Inc.Momentum Trend Signal Weekly Recap Summary - Newser
Is Black Diamond Therapeutics Inc. a Top Dividend Stock to Watch in 2025Free Weekly Hot Picks With Buy Confidence - Newser
Black Diamond Therapeutics (NASDAQ:BDTX) Downgraded by Wall Street Zen to “Hold” - Defense World
Black Diamond Therapeutics, Inc.'s (NASDAQ:BDTX) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects? - Yahoo Finance
Black Diamond Therapeutics Reports Q2 Earnings with $45.98M Net Income and $70M Upfront Payment from Servier Agreement - AInvest
Black Diamond Therapeutics Maintains Buy Rating with $11 Price Target - AInvest
Black Diamond Therapeutics Slims Losses And Stays Flush With Cash - Finimize
Historical volatility pattern of Black Diamond Therapeutics Inc. visualizedFree Daily Chart Pattern Stock Forecast - Newser
Black Diamond Therapeutics Cuts Losses And Eyes Silevertinib Growth - Finimize
Black Diamond Therapeutics shares rise 1.75% premarket after reporting a narrower Q2 net loss and exploring partnerships for silevertinib development. - AInvest
Black Diamond: Q2 Earnings Snapshot - Stamford Advocate
Black Diamond Therapeutics Inc (BDTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Black Diamond Therapeutics Inc 주식 (BDTX) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Versant Venture Capital VI, L. | 10% Owner |
Aug 28 '24 |
Sale |
6.32 |
221,600 |
1,400,556 |
3,726,341 |
자본화:
|
볼륨(24시간):